Welcome to the “news” section of our website, where you'll find all the latest publications on our advances in research (Alzheimer's, Parkinson's, Charcot's disease, etc.), our upcoming events, etc.
MedDay, a biotechnology company centred on disorders of the nervous system and incubated at the Brain and Spine Institute – Institut du Cerveau - ICM, announced today that the main criterion of its pivotal clinical trial MS-SPI was attained. The...
